Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis.
作者信息
Burness Monika L, Wicha Max S
机构信息
University of Michigan Comprehensive Cancer Center, Michigan Medicine, Ann Arbor, MI, USA.
出版信息
Cell Res. 2018 Apr;28(4):391-392. doi: 10.1038/s41422-018-0028-4.
Abstract
摘要
相似文献
1
Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis.他莫昔芬与雌激素受体α36：为乳腺癌转移播下种子
Cell Res. 2018 Apr;28(4):391-392. doi: 10.1038/s41422-018-0028-4.
2
Tamoxifen enhances stemness and promotes metastasis of ERα36 breast cancer by upregulating ALDH1A1 in cancer cells.他莫昔芬通过上调癌细胞中的 ALDH1A1 增强 ERα36 乳腺癌的干性并促进其转移。
Cell Res. 2018 Mar;28(3):336-358. doi: 10.1038/cr.2018.15. Epub 2018 Feb 2.
3
Structural insights into tumor-specific chaperoning activity of gamma synuclein in protecting estrogen receptor alpha 36 and its role in tamoxifen resistance in breast cancer.γ-突触核蛋白在保护雌激素受体α36中的肿瘤特异性伴侣活性的结构见解及其在乳腺癌 tamoxifen 耐药中的作用
Mol Biosyst. 2015 Nov;11(11):2998-3010. doi: 10.1039/c5mb00272a.
4
Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.他莫昔芬和柚皮素的组合抗增殖作用：四种雌激素受体亚型的作用。
Toxicology. 2018 Dec 1;410:231-246. doi: 10.1016/j.tox.2018.08.013. Epub 2018 Aug 25.
5
Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.体外研究表明，膜相关雌激素受体 ER-α36 信号转导介导了他莫昔芬耐药和人乳腺癌细胞的转移。
Cell Biol Toxicol. 2017 Apr;33(2):183-195. doi: 10.1007/s10565-016-9365-6. Epub 2016 Nov 11.
6
Effects of tamoxifen and toremifene on ALDH1 and ALDH3 in human retinal pigment epithelial cells and rat liver.
Adv Exp Med Biol. 1999;463:151-8. doi: 10.1007/978-1-4615-4735-8_18.
7
Estrogen receptor polymorphisms in tamoxifen-treated women with breast cancer.他莫昔芬治疗的乳腺癌女性中的雌激素受体多态性
Gynecol Endocrinol. 2006 Apr;22(4):185-9. doi: 10.1080/09513590600645767.
8
The Effect of P-Glycoprotein (P-gp), Nuclear Factor-Kappa B (Nf-κb), and Aldehyde Dehydrogenase-1 (ALDH-1) Expression on Metastases, Recurrence and Survival in Advanced Breast Cancer Patients.P-糖蛋白（P-gp）、核因子-κB（Nf-κb）和乙醛脱氢酶-1（ALDH-1）表达对晚期乳腺癌患者转移、复发及生存的影响
Asian Pac J Cancer Prev. 2019 May 25;20(5):1511-1518. doi: 10.31557/APJCP.2019.20.5.1511.
9
Tamoxifen, an anticancer drug, is an activator of human aldehyde dehydrogenase 1A1.他莫昔芬是一种抗癌药物，是人类醛脱氢酶1A1的激活剂。
Proteins. 2015 Jan;83(1):105-16. doi: 10.1002/prot.24709. Epub 2014 Nov 18.
10
Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.雌激素受体α转录共调节因子在乳腺癌他莫昔芬耐药中的作用
Maturitas. 2006 Jul 20;54(4):342-51. doi: 10.1016/j.maturitas.2006.06.003. Epub 2006 Jul 5.
本文引用的文献
1
Tamoxifen enhances stemness and promotes metastasis of ERα36 breast cancer by upregulating ALDH1A1 in cancer cells.他莫昔芬通过上调癌细胞中的 ALDH1A1 增强 ERα36 乳腺癌的干性并促进其转移。
Cell Res. 2018 Mar;28(3):336-358. doi: 10.1038/cr.2018.15. Epub 2018 Feb 2.
2
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.芳香酶抑制剂与他莫昔芬治疗早期乳腺癌：随机试验的患者水平荟萃分析。
Lancet. 2015 Oct 3;386(10001):1341-1352. doi: 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23.
3
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.他莫昔芬预防乳腺癌：IBIS-I 乳腺癌预防试验的长期随访。
Lancet Oncol. 2015 Jan;16(1):67-75. doi: 10.1016/S1470-2045(14)71171-4. Epub 2014 Dec 11.
4
ER-α36-mediated rapid estrogen signaling positively regulates ER-positive breast cancer stem/progenitor cells.雌激素受体α36介导的快速雌激素信号传导正向调节雌激素受体阳性乳腺癌干细胞/祖细胞。
PLoS One. 2014 Feb 18;9(2):e88034. doi: 10.1371/journal.pone.0088034. eCollection 2014.
5
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.选择性雌激素受体调节剂在乳腺癌预防中的应用：一项个体参与者数据的更新荟萃分析。
Lancet. 2013 May 25;381(9880):1827-34. doi: 10.1016/S0140-6736(13)60140-3. Epub 2013 Apr 30.
6
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.乳腺癌激素受体及其他因素与辅助他莫昔芬疗效的相关性：随机试验的患者水平荟萃分析。
Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28.
7
Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.雌激素通过旁分泌 FGF/Tbx3 信号扩大乳腺癌干细胞样细胞。
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21737-42. doi: 10.1073/pnas.1007863107. Epub 2010 Nov 22.
8
Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer.雌激素受体α的新型变体ER-α36的表达与乳腺癌对他莫昔芬治疗的耐药性
J Clin Oncol. 2009 Jul 20;27(21):3423-9. doi: 10.1200/JCO.2008.17.2254. Epub 2009 Jun 1.
9
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.醛脱氢酶1（ALDH1）是正常和恶性人乳腺干细胞的标志物，也是临床预后不良的预测指标。
Cell Stem Cell. 2007 Nov;1(5):555-67. doi: 10.1016/j.stem.2007.08.014.
10
Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66.人雌激素受体α66的新型变体——人雌激素受体α36的鉴定、克隆与表达
Biochem Biophys Res Commun. 2005 Nov 4;336(4):1023-7. doi: 10.1016/j.bbrc.2005.08.226.
Zotero 插件